QA: GRI Bio Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001824293_2022_GRI_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001824293, GRI Bio Inc

  xvar xval
0 AssetsCurrent 8,129,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 206,000
4 LiabilitiesCurrent 2,445,000
5 LiabilitiesNoncurrent 72,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,072,000
9 ResearchAndDevelopmentExpense 5,187,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -44,000
13 remainder_ComprehensiveNetIncome -2,000
  yvar yval
0 Assets 8,335,000
1 Liabilities 2,517,000
2 Expenses 9,259,000
3 Revenues 0
4 StockholdersEquity 5,818,000
5 NetIncome -9,303,000
6 ComprehensiveNetIncome -9,304,000
7 BaseVar 10,078,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.623
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution